רקויפ מודוטאב 4 מ"ג

País: Israel

Idioma: hebreu

Font: Ministry of Health

ingredients actius:

ROPINIROLE AS HYDROCHLORIDE 4 MG

Disponible des:

GLAXO SMITH KLINE (ISRAEL) LTD

Codi ATC:

N04BC04

formulario farmacéutico:

FILM COATED TABLETS - PROLONGED RELEASE

Vía de administración:

PER OS

Fabricat per:

SMITHKLINE BEECHAM PLC, UK

Grupo terapéutico:

ROPINIROLE

indicaciones terapéuticas:

Ropinirole is indicated for the treatment of Parkinson's disease. Ropinirole is effective as early therapy in patients requiring dopaminergic therapy. As adjunctive treatment to L-dopa, ropinirole enhances the efficacy of L-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic L-dopa therapy and permits reduction in daily L-dopa dose.

Data d'autorització:

2009-09-01